 Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA Analysts at Wedbush raised their Q2 2020 EPS estimates for Kiniksa Pharmaceuticals in a research report issued to clients and investors on Wednesday, April 29th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of 0.60 per share for the quarter, up from their previous forecast of ... 